Head Neck Tumors

1

Review clinical trials related to Head Neck Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.

Single-arm, monocentric trial to assess safety and immunological efficacy of adjuvant vaccination with autologous dendritic cells loaded with autologous tumour homogenate after curative resection for stage IV rare cancers (In Head/Neck tumors (H\&N), NEuroendocrine Tumors (NET) and Soft Tissue Sarcomas (STS).

Participants needed: 51
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Patients must have histologically confirmed stage IV Head&Neck Squamous Cell Car... [+16]

Patients with residual disease after surgery. Marginal resection of any lesion i... [+10]